glp-1 microdosing vs full dose Microdosing: Risks, Benefits and What to Know Before Changing Your THE PCCA BLOG | Microdosing

Microdosing as an Entry Point or Exit Strategy Chris Michaelis, DO, owner of Luminus Aesthetics, said microdosing often serves as an entry point or an exit strategy, depending on the patient

GLP-1 drugs have been linked to several eye problems, including: Non-arteritic anterior ischemic optic neuropathy (NAION) Optic neuropathy Retinal ischemia Exacerbation of diabetic retinopathy These GLP-1 eye problems can range from mild visual field defects to complete blindness in one eye

Wegovy (semaglutide 2.4 mg) can generally be taken safely after gallbladder removal, and having undergone cholecystectomy is not listed as a contraindication to treatment in the Summary of Product Characteristics approved by the Medicines and Healthcare products Regulatory Agency (MHRA)

Herbs like oregano, clove, eucalyptus, rosemary, cinnamon, ginger, and curcumin are all-natural biofilm disruptors